Adrenocortical carcinoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable prognosis. Here we summarize the knowledge about diagnosis, epidemiology, pathophysiology, and therapy of ACC. Over recent years, multidisciplinary clinics have formed and the first international treatment trials have been conducted. This review focuses on evidence gained from recent basic science and clinical research and provides perspectives from the experience of a large multidisciplinary clinic dedicated to the care of patients with ACC.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Endocr Rev

Title: Endocrine reviews

Publisher: The Endocrine Society

ISSN (Electronic): 1945-7189

ISSN (Print): 0163-769X

Publication date (Electronic): Apr 2014

Volume: 35

Issue: 2

Affiliations

[1 ] MEND/Division of Metabolism, Endocrinology, and Diabetes (T.E., T.J.G., G.D.H.), Division of Molecular Medicine and Genetics (V.M.R.), Department of Internal Medicine; Departments of Radiation Oncology (A.S., J.S.), Pathology (T.J.G.), and Radiology (A.K., E.M.C.); and Division of Endocrine Surgery (B.S.M.), Section of General Surgery, (A.C.K.), Department of Surgery, University of Michigan Hospital and Health Systems, Ann Arbor, Michigan 48109.

Article

DOI: 10.1210/er.2013-1029

PMC ID: 3963263

PubMed ID: 24423978

SO-VID: ed8b6be1-5935-4601-bb6c-575cb04aa53a

History

Data availability:

Comments

Comment on this article

scite_

Cited by 294

See all cited by

- Version 1